Clinical Trial Update: Oral Contraceptives in the Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral contraceptives in individuals with metabolic syndrome and insulin resistance; study completed with posted results in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Insulin Resistance
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Metabolic Syndrome X, Insulin Resistance | Phase 4 | Status: COMPLETED | Results posted: 2012-05-07